ANTIBIOTIC RESISTANCE: AN OBSERVATIONAL STUDY FROM INTENSIVE CARE UNIT OF PEOPLE UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, NAWAB SHAH SINDH, PAKISTAN.
Main Article Content
Keywords
Antibiotic, resistance, Medical, Streptococcus
Abstract
Infectious diseases are very common in all age groups and intensive care units are very sensitive areas of any hospital patients are very critical and all measures are adopted to avoid any sort of contamination and transmission of infections. Despite of that infections are frequently reported from theses sensitive areas of the hospitals. This study was conducted to evaluate the common pathogens responsible for in such population of patients. Antibiotic resistance is another challenge faced by the treating physicians indoor, out door and critically ill patients so the current research work also focused on this aspect of treatment and evaluated the response of antibiotic therapy against various pathogens by assessing culture and sensitivity in the samples obtained from patients admitted in the intensive care unit of the people university of medical and health sciences shaheed Benazir Abad (Nawab Shah, Sindh). Patients were selected through purposive and consecutive sampling, blood, urine and swab samples were collected under aseptic measures from patients running fever. There were 42 such cases evaluated the mean age of the study participants was 17.38+7.13 years with the minimum age as 11 years while the maximum as 60 years. Common pathogens found on culture and sensitivity reports after 72 hours of incubation were Proteus, Klebsiella, Staphylococcus and Streptococcus. Cephalosporins, Penicillin group, Macrolides, Fluroquinolones, Linezolid, Aminoglycosides, Meropenem and Fosfomycin were the common antibiotics tested. There 26(61.90%) males and 16(38.10%) females and bacterial growth was seen in 10(23.81%) of the patients while no bacterial growth was reported for 32(76.19%) patients after an incubation of 48 hours. Proteus was found sensitive to Meropenem and Amikacin while Klebsiella was found sensitive to Fosfomycin and Imipenem.
References
2. B. Pezhman, R. Fatemeh, R. Amir, R. Mahboobeh, F. Mohammad Nosocomial infections in an Iranian educational hospital: an evaluation study of the Iranian nosocomial infection surveillance system BMC Infect. Dis.,2021;21(1): 1256
3. Vaskar Majumdar, Mohit Aggarwal, Antimicrobial Resistance In Intensive Care Units Is An Alarming Public Health Issue – A Review Article. Futuristic Trends in Medical Sciences 2024; 3(3):196 -202
4. Metin Kilinc, Antibiotic Resistance and Mortality in ICU Patients: A Retrospective Analysis of First Culture Growth Results. Antibiotics 2025, 14(3), 290; https://doi.org/10.3390/antibiotics14030290
5. Du, L., Teng, J., Zhou, A., Wang, Q., Deng, S., Zhao, Y., Li, J., & Imani, S. Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2023; 167, 115564 . https://doi.org/10.1016/j.biopha.2023.115564.
6. Tran GM, Ho-Le TP, Ha DT, Tran-Nguyen CH, Nguyen TSM et al. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC Infect Dis. 2017;17(1):429. doi: 10.1186/s12879-017-2529-z.
7. Carlet, J., Garnacho-Montero, J., De Backer, D., Zahar, J., Roberts, J.et al. antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Medicine,2018; 44, 189-196.
8. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 2022; 399(10325): 629-655
9. Drug-Resistant Infections: A Threat to Our Economic future (March 2017) https://www.worldbank.org/en/topic/health/publication/drug-resistant-infections-a-threat-to-our-economic-future
10. Jamie Kisgen, Principles of Antimicrobial Therapy UNIT VI Chemotherapeutic Drugs, Lippincott illustrated Reviews pharmacology 13th edition Karen Wolen, Walter Kluwer’s 2019;489-504
11. A.A. Chiș, L.L. Rus, C. Morgovan, A.M. Arseniu, A. Frum, A.L. Vonica-țincu, F.G. Gligor, M.L. Mureșan, C.M. Dobrea Microbial Resistance to Antibiotics and Effective Antibiotherapy Biomedicines, 2022;10: 1121, 10.3390/biomedicines10051121
12. H. Mohanty, S. Pachpute, R.P. Yadav.Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers
Folia Microbiol. Praha, 2021; 66:727-739, 10.1007/s12223-021-00910-z
13. Feßler A.T., Wang Y., Wu C., Schwarz S. Mobile macrolide resistance genes in staphylococci. Plasmid. 2018;99:2–10. doi: 10.1016/j.plasmid.2018.05.001.
14. Wilson DN. Nat Rev Microbiol. 2014;12:35–48. doi: 10.1038/nrmicro3155.
15. Aldred K. J.; McPherson S. A.; Wang P.; Kerns R. J.; Graves D. E.; Turnbough C. L. Jr.; Osheroff N. (2012) Drug interactions with Bacillus anthracis topoisomerase IV: Biochemical basis for quinolone action and resistance. Biochemistry 51, 370–381.
16. Aldred K. J.; McPherson S. A.; Turnbough C. L. Jr.; Kerns R. J.; Osheroff N. (2013) Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: Mechanistic basis of quinolone resistance. Nucleic Acids Res. 41, 4628–4639.